United States Peripheral Angioplasty Market Size, Share, and COVID-19 Impact Analysis, By Product (Balloon Catheters, Stents, and Guidewires), By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Catheterization Centers), and United States Peripheral Angioplasty Market Insights, Industry Trend, Forecasts to 2035

United States Peripheral Angioplasty Market Insights Forecasts to 2035

• The USA Peripheral Angioplasty Market Size is Expected to Grow at a CAGR of around 6.8% from 2025 to 2035.
• The United States Peripheral Angioplasty Market Size is Expected to Hold a Significant Share by 2035.

According to a research report published by Spherical Insights & Consulting, the United States Peripheral Angioplasty Market Size is Expected to hold a significant share by 2035, Growing at a CAGR of 6.8% from 2025 to 2035. The United States peripheral angioplasty market growth is driven by rising peripheral artery disease prevalence, especially among aging and diabetic populations. Technological innovations like drug-coated balloons and bioresorbable stents improve treatment outcomes. Additionally, increased preference for outpatient procedures, supportive reimbursement policies, and expanding healthcare infrastructure enhance accessibility and adoption, fueling sustained market expansion.

Market Overview

The United States peripheral angioplasty market encompasses minimally invasive procedures aimed at treating peripheral artery disease (PAD) and other vascular conditions affecting limbs. These interventions, including balloon angioplasty, stenting, and atherectomy, restore blood flow and reduce complications like limb ischemia. The market is driven by the increasing prevalence of PAD, particularly among the aging population and individuals with diabetes and hypertension. Technological advancements, such as drug-eluting balloons, bioresorbable stents, and improved imaging techniques, have enhanced treatment outcomes and reduced restenosis rates. A well-developed healthcare system, an informed patient base, and the presence of top medical device firms collectively form the core strengths of the market. Expanding outpatient care facilities like ambulatory surgical centers, which provide affordable and convenient treatments, presents a significant opportunity. Supportive government initiatives, including favourable reimbursement policies from Medicare and private insurers, have improved patient access to these procedures. Overall, ongoing innovation and increased adoption of minimally invasive techniques position the U.S. peripheral angioplasty market for sustained growth in the coming years.

Report Coverage

This research report categorizes the market for the United States peripheral angioplasty market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the USA peripheral angioplasty market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the U.S. peripheral angioplasty market.

Driving Factors

The rising prevalence of peripheral artery disease (PAD), particularly among the aging population and individuals with diabetes and hypertension, significantly increases the demand for effective treatments. Growing awareness about PAD and its potential complications leads to higher diagnosis rates and greater patient acceptance of minimally invasive procedures. Technological innovations such as drug-coated balloons, bioresorbable stents, and advanced atherectomy devices have improved procedural success and patient outcomes, boosting market growth. Additionally, the shift toward outpatient care settings like ambulatory surgical centers offers more cost-effective and convenient treatment options, further encouraging adoption. Supportive reimbursement policies from Medicare and private insurers enhance accessibility, while expanding healthcare infrastructure and increased healthcare spending continue to fuel demand for advanced peripheral angioplasty interventions.

Restraining Factors

The high cost of advanced devices and procedures can limit patient access and adoption. Additionally, stringent regulatory requirements may delay product approvals, while reimbursement challenges can restrict market growth. Limited awareness in certain populations also hinders early diagnosis and timely treatment of peripheral artery disease.

Market Segmentation

The United States peripheral angioplasty market share is classified into product and end user.

• The balloon catheters segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The USA peripheral angioplasty market is segmented by product into balloon catheters, stents, and guidewires. Among these, the balloon catheters segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their central role in minimally invasive procedures to open narrowed or blocked blood vessels. Their widespread use in both standalone angioplasty and as a preparatory step before stent placement makes them essential, driving higher demand compared to stents and guidewires.

• The hospitals segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The U.S. peripheral angioplasty market is segmented by end user into hospitals, ambulatory surgical centers, and cardiac catheterization centers. Among these, the hospitals segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the availability of advanced infrastructure, skilled healthcare professionals, and comprehensive emergency care. Hospitals handle a high volume of complex vascular procedures and are often the first point of care for critical cases, making them the primary setting for peripheral angioplasty interventions.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States peripheral angioplasty market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boston Scientific Corporation
• Merit Medical Systems
• Vascular Solutions, Inc.
• Teleflex Incorporated
• Abbott Laboratories
• Shockwave Medical
• Gore & Associates
• AngioDynamics
• Penumbra, Inc.
• Surmodics, Inc.
• Abiomed, Inc.
• Cook Medical
• Inari Medical
• Medtronic
• Cordis
• Others

Recent Developments:

• In March 2024, Boston Scientific received U.S. FDA approval for the AGENT™ Drug-Coated Balloon (DCB), the first coronary drug-coated balloon in the U.S. indicated for treating coronary in-stent restenosis (ISR). The approval was based on positive results from the AGENT IDE trial, which demonstrated the device's superiority over uncoated balloon angioplasty in reducing target lesion failure and adverse events at 12 months. The AGENT DCB is expected to provide a safe and effective alternative to traditional therapies, addressing a critical unmet need in the treatment of ISR.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the U.S., regional, and country levels from 2020 to 2035. Spherical Insights has segmented the USA peripheral angioplasty market based on the below-mentioned segments:

United States Peripheral Angioplasty Market, By Product

• Balloon Catheters
• Stents
• Guidewires

United States Peripheral Angioplasty Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Centers